Global Insulin Glargine Market Size is projected to reach USD 2200 million by 2031, growing at a CAGR of 6.11%: Straits Research New York, United States, March 20, 2024 (GLOBE NEWSWIRE) -- Insulin glargine is a modified, long-acting form of medical insulin used to treat diabetes types I and II. It is subcutaneously injected....

Global Insulin Market Size Worth USD 790.7 Million in 2032 | Emergen Research Vancouver, Dec. 28, 2023 (GLOBE NEWSWIRE) -- The global insulin market size was USD 570.8 Million in 2022 and is expected to register a steady revenue CAGR of 3.3% during the forecast period,...